SCHEMBL22148790

SCHEMBL22148790

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc(-c4nc(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)c(-n5c6ccccc6c6ccccc65)c4-n4c5ccccc5c5ccccc54)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.42
ATM Q13315 2/20 0.42
MEN1 O00255 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ACP1 P24666 3/20 0.35
NPY5R Q15761 1/20 0.35
DPP4 P27487 4/20 0.35
HSD17B10 Q99714 1/20 0.35
PDE5A O76074 1/20 0.35
MAPT P10636 2/20 0.34
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
MAPK1 P28482 1/20 0.33
HTT P42858 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
LMNA P02545 1/20 0.33
ACHE P22303 1/20 0.33
RORC P51449 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21888843 0.94 ATM (0.38) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL22148792 0.91 MEN1 (0.34) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL22148881 0.89 KMT2A (0.43) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL22148791 0.88 TSHR (0.35) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL21888639 0.87 KMT2A (0.41) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL21888845 0.85 MEN1 (0.41) KMT2AMEN1L3MBTL1KDM4EHSD17B10
SCHEMBL21838752 0.85 ATM (0.49) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL21889501 0.84 MEN1 (0.40) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL23177403 0.83 ACP1 (0.45) KMT2AATMMEN1L3MBTL1KDM4E
SCHEMBL23177233 0.83 KMT2A (0.46) KMT2AATMMEN1L3MBTL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX, INC. (JP) 2020-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200203622-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES NDUFV3, NDUFV2, CRY2 KMT2A 4367/4885ATM 2778/4885MEN1 2193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.